NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Hyku Biosciences

Hyku Biosciences

Private
Burlington, MassachusettsHealthcare & Life Scienceshttps://www.hykubiosciences.com/

Last Round

Seed Round

Jun 10, 2026

Total Funding Raised

$64M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Hyku Biosciences is a biotechnology company that develops small molecule therapeutics with innovative mechanisms designed to effectively inactivate disease-driving proteins.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

covalent therapeuticschemoproteomicsdrug discoverycovalent inhibitorsundruggable targetsoncology therapeuticstargeted protein degradationsmall molecule drugscomputational chemistryproteomicsbiotech platformhit-to-leadnext-gen drug discoveryprecision medicinerational drug design

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Hyku Biosciences Comparables

Compare Hyku Biosciences with similar companies based on industry and business-model similarity.

Hyku Biosciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Matchpoint Therapeutics
82%
Totus Medicines
81%
Frontier Medicines
81%

Hyku Biosciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Seed RoundJun 10, 2026
Seed RoundMar 2, 2026
SeedNov 12, 2024
SeedSep 19, 2023

Hyku Biosciences Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 22, 2026

    Monthly visitors increased 32% MoM, reaching 2K.

  • Jun 10, 2026

    Raised $1.3M in a seed round.

Hyku Biosciences Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Hyku Biosciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Hyku Biosciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersBurlington, Massachusetts
Employee Range12
Year Founded2023
Last FundingJun 10, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.